Diagnostics News and Research

RSS

HHS awards $56.9 million to tackle health disparities

HHS Secretary Mike Leavitt has announced the awarding of $56.9 million by the National Institutes of Health’s (NIH) National Center on Minority Health and Health Disparities (NCMHD).

10 Jan 2006

Targeted cancer therapies: Another step forward

While it is clear that the treatment of cancer has already begun to undergo a paradigm shift with the inclusion of innovative targeted therapies into current regimens, it would be wrong to assume these products will entirely replace traditional chemotherapy as the standard treatment for cancer sufferers.

22 Dec 2005

Targeted cancer therapies: Another step forward

22 Dec 2005

Microfluidics chips for simplifying medical imaging biomarkers of disease

A collaboration between scientists at UCLA, Caltech, Stanford, Siemens and Fluidigm have developed a new technology using integrated microfluidics chips for simplifying, lowering the cost and diversifying the types of molecules used to image the biology of disease with the medical imaging technology, Positron Emission Tomography (PET).

15 Dec 2005

DNA strands for biologically based electronics and medical devices

Ohio State University researchers have invented a process for uncoiling long strands of DNA and forming them into precise patterns.

15 Dec 2005

AMN107 drug shows promise in leukemia resistance to Gleevec

The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.

13 Dec 2005

Analysis of the regulatory hurdles in European Diagnostics

In a move aimed at harmonising diagnostics regulations, the European parliament amended the medical devices directive (MDD) of 1993 to bring in the IVD directive (98/79/EC) in 1998.

6 Dec 2005

Diagnostics test for monitoring anti-HIV drugs hits European market

The test has been acquired by Delphic Europe - a diagnostics products provider - which will develop it in conjunction with viral resistance testing for market on the continent. The service was created by Professor David Back, Dr Saye Khoo and a team in the School of Biomedical Science and is currently used to analyse blood samples from patients with HIV across the UK in order to identify the correct dosage of medicine for individual patients.

7 Nov 2005

New device to detect early signs of heart conditions

A Yorkshire heart-monitor company is one of five technology businesses hoping to raise finance at the White Rose Bioscience Forum, Yorkshire’s flagship bioscience event - in York today (01 November 2005).

1 Nov 2005

Dead human tissue illegally used in surgery

London Health Sciences Centre is investigating if its surgeons used human tissue products that were recalled because they might have been taken illegally from corpses at funeral homes in the United States.

31 Oct 2005

New strategies to help developing countries address neglected diseases

For the health challenges facing developing countries, the numbers alone are staggering. Every day, 40,000 people - enough to fill a sports stadium - die from preventable infectious diseases and malnutrition. Entire generations of human potential are perishing.

25 Oct 2005

Lack of gene expression associated with ovarian cancer

The expression of two specific genes is almost completely downregulated in ovarian cancer tumours. An extensive analysis of gene expression in ovarian cancer tumour cells has revealed this important finding, which should be an aid to early diagnosis.

24 Oct 2005

Natural selection has played an important role in patterning the human genome

The most detailed analysis to date of how humans differ from one another at the DNA level shows strong evidence that natural selection has shaped the recent evolution of our species, according to researchers from Cornell University, Celera Genomics and Celera Diagnostics.

23 Oct 2005

Cutting-edge research to develop this range of next-generation biomedical devices

Revolutionary new self-diagnostic devices to provide early warning of deadly and debilitating illnesses like cancer, diabetes and heart disease are the aim of a Euro 22.5m Science Foundation Ireland research facility to be established at Dublin City University.

18 Oct 2005

Third Wave Technologies files patent suits against Chiron and Bayer

The company last Friday filed suit against Digene Corp., seeking a court ruling supporting Third Wave's right to sell its human papilloma virus (HPV) products. Third Wave today also filed suit against Chiron Corp., Bayer Corp., and Bayer HealthCare LLC asking for a similar ruling about its right to sell its hepatitis C virus products.

11 Oct 2005

Nanogen subsidiary, Epoch Biosciences issued new patent

Nanogen announced today its subsidiary, Epoch Biosciences, was issued Patent No. 6,951,930, "Hybridization-Triggered Fluorescent Detection of Nucleic Acids" by the U.S. Patent and Trademark Office.

11 Oct 2005

Most comprehensive picture to date of how influenza viruses evolve and are transmitted

In the first large-scale effort of its kind, researchers have determined the full genetic sequence of more than 200 distinct strains of human influenza virus.

5 Oct 2005

Tuberculosis infection prevention by quick testing

With a new DNA test, tuberculosis infection can be revealed so quickly that a patient doesn’t have time to infect others. This can be an important key to effective control of the disease.

28 Sep 2005

Adlyfe receives award from the development of blood test for animal prion diseases

Adlyfe, Inc., a privately held biotech company headquartered in Rockville, MD, focused on early diagnostics for animal and human brain diseases announced the award today of a $650,000 two year grant from the Department of Environment, Food and Rural Affairs (DEFRA) in the UK for continued development of a sensitive early blood test for animal prion diseases.

7 Sep 2005

Potential new way to fight HIV

Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology.

1 Sep 2005